Phenoxymethylpenicillin-AFT (Penicillin V) now in Australia

In addition to the four products on the Pharmaceutical Schedule, Budenocort Powder for Inhalation, Aramed, Acetadote IV and Provive MCT-LCT. Australia, AFT Pharmaceuticals is delighted to achieve further PBS listings to the four listed, Phenoxymethylpenicillin-AFT (Penicillin V) Oral Liquid 125mg/5ml & 250mg/5ml strengths on the PBS from 01 June 2011.

This restores the original penicillin oral liquid strengths to the PBS adding to choice available to Australian doctors and patients.

“These new listings will add to AFT’s extensive list of products on the Pharmaceutical Schedule”, said CEO and founder Dr Hartley Atkinson.

May 1, 2024

AFT Licenses Maxigesic® IV in Brazil

We are delighted to announce our partnership with Brazil’s Halex Istar, and to be exclusively responsible for distributing its Maxigesic IV in Brazi…

Read More

April 24, 2024

AFT, Massey Ventures, Gilles McIndoe to develop scar treatment

AFT collaborate with Massey Ventures and Gilles McIndoe to begin the development of a topical treatment for keloid and hypertrophic scarring….

Read More

March 5, 2024

AFT makes further progress in international markets

AFT Pharmaceuticals provides an update on recent progress it has made in international markets….

Read More